Llwytho...
Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves’ orbitopathy
BACKGROUND: Rapamycin (alternatively known as sirolimus) is a macrolide immunosuppressant commonly used for organ transplantation. It acts both on lymphocytes through the mechanistic target of rapamycin (mTOR) pathway to reduce their sensitivity to interleukin-2 (IL-2) and, importantly, also has ant...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Eye (Lond) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group UK
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461882/ https://ncbi.nlm.nih.gov/pubmed/30755726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-019-0340-3 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|